Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M215Revenue $M13.3Net Margin (%)-208.0Altman Z-Score-38.7
Enterprise Value $M269EPS $-0.2Operating Margin %-140.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-217.1Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.9Cash flow > EarningsY
Price/Sales15.95-y EBITDA Growth Rate %-24.6Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-178.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M156ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with NAVB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NAVBJohn Keeley 2015-12-31 Sold Out $1.33 - $2.37
($1.72)
$ 1.38-20%Sold Out0
NAVBJohn Keeley 2015-06-30 Buy $1.24 - $1.67
($1.45)
$ 1.38-5%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NAVB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NAVB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-12-01Sell12,500$1.5-8view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-11-02Sell12,500$1.98-30.3view
LARSON BRENT LEVP, CFO, Treas & Sec'y 2015-10-01Sell12,500$2.27-39.21view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-09-01Sell12,500$1.88-26.6view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-08-03Sell12,500$1.71-19.3view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-06-01Sell12,500$1.2411.29view
Troup Gordon ADirector 2015-05-29Buy10,000$1.315.34view
FORD BRENDAN ADirector 2015-05-21Buy20,000$1.315.34view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-05-01Sell12,500$1.333.76view
LARSON BRENT LEVP, CFO, Treas and Sec'y 2015-04-01Sell20,000$1.58-12.66view

Quarterly/Annual Reports about NAVB:

News about NAVB:

Articles On GuruFocus.com
Navidea Biopharmaceuticals Reports 4 Insider Trades Mar 18 2013 

More From Other Websites
Navidea Appoints Jed Latkin as Interim Chief Operating Officer Apr 26 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 26 2016
Navidea Appoints Jed Latkin as Interim Chief Operating Officer Apr 26 2016
Navidea & Macrophage Therapeutics Business Update Call scheduled for 4:30 pm ET today Apr 18 2016
Here's Why Navidea Biopharmaceuticals Surged 25% Apr 15 2016
Navidea and Macrophage Therapeutics to Provide Business Update Apr 15 2016
Navidea and Macrophage Therapeutics to Provide Business Update Apr 15 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Triggering Events That Accelerate or Increase a... Apr 13 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers,... Apr 06 2016
Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid... Apr 04 2016
Navidea Updates Clinical Development Plan for Diagnostic Use of Lymphoseek® IV in Rheumatoid... Apr 04 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 29 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Financials Mar 29 2016
After Guiding for 300% Growth, Company Lands Order That No One Noticed Mar 29 2016
Navidea Biopharmaceuticals, Inc. :NAVB-US: Earnings Analysis: 2015 By the Numbers Mar 28 2016
Edited Transcript of NAVB earnings conference call or presentation 23-Mar-16 12:00pm GMT Mar 24 2016
NAVIDEA BIOPHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Mar 23 2016
Navidea Biopharmaceuticals Inc Earnings Call scheduled for 8:00 am ET today Mar 23 2016
Q4 2015 Navidea Biopharmaceuticals Inc Earnings Release - Before Market Open Mar 23 2016
Navidea Announces Fourth Quarter and Full Year 2015 Results Mar 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)